Market Analysis
Latest Market Analysis News
China owns THIS a lot stake in Pakistan Inventory Alternate, information reveals amid US-China deal
China's increasing geopolitical possession exhibits that the Asian nation owns a major stake in Pakistan and Bangladesh's inventory exchanges by…
10 Worst Performing Mutual Funds within the Final 10 Years (0.72% to six.2% CAGR Returns)
Over the previous decade, the Indian inventory market has seen a outstanding rally. From 12-Could-2015 to 11-Could-2025, the Nifty 50…
Airtel This fall Preview: ARPU Secure, 5G Boosts Progress
Bharti Airtel's This fall FY25 India outcomes are anticipated to indicate secure ARPU, sturdy subscriber good points, and 38% YoY…
Amazon share value jumps over 7% on US markets after US-China deal reveals an upcoming 115% tariff minimize
Amazon Inc. share value jumped greater than 7 per cent within the US market session on Monday, Might 12, after…
GAIL India This autumn FY25 Outcomes Preview & Funding Outlook
GAIL is about to report This autumn FY25 outcomes on Might 13. Buyers await updates on fuel volumes, margins, dividend,…
Distinction Between Particular person and HUF Demat Accounts
Embarking on the journey of investing within the Indian inventory market requires opening a Demat account. This dematerialised account holds…
Edelweiss MF CEO Radhika Gupta flags problem in timing the market: ‘For us dumber buyers…’
Edelweiss Mutual Fund CEO Radhika Gupta highlighted the problem of timing the inventory market in gentle of the sharp rally…
How lengthy will it take to achieve Rs 5 crore?
Let's discover the reply, as reaching this objective is determined by your funding fee, time horizon and psychology>
48 shares hit 52-week lows, 110 shares at 52-week highs as Sensex, Nifty 50 finish greater over 3% on India-Pakistan truce
48 shares hit 52-week lows, 110 shares at 52-week highs as Sensex, Nifty 50 finish greater over 3% on India-Pakistan…
Solar Pharma tanks 3% as Trump's drug transfer hits onerous
Indian pharma's world chief takes a success as US targets excessive costs>